Management of generalized anxiety disorder with lm potencies: a case report
Homoeopathy for Generalized Anxiety Disorder
Abstract
Background: Generalized Anxiety Disorder (GAD) is a common mental health condition characterized by persistent and excessive worry or anxiety about various aspects of life, such as work, relationships, and daily activities. Anxiety disorders can result in work and school absences, posing a greater financial burden compared to other psychiatric disorders, given their higher global prevalence of approximately 642 million individuals affected. Although effective psychological treatments like Cognitive-Behavioral Therapy and mindfulness-based therapies exist for GAD, accessibility remains an issue for many. Common medications, including Selective Serotonin Reuptake Inhibitors and Benzodiazepines, carry potential side effects. While there has been some exploration of Homoeopathy's effectiveness in GAD, comprehensive discussions on the approach and posology are lacking.
Case summary: A 52-year-old female patient, exhibiting symptoms of generalized anxiety coupled with severe autonomic symptoms, was diagnosed with GAD based on DSM-5 criteria. The cases were systematically analyzed and treated with individualized homeopathic medicines in fifty millesimal potencies. The approach involved initial blood tests and thyroid function assessments to rule out systemic illnesses. Thorough case assessments were conducted using standardized record forms and the Kentian method to compile a comprehensive symptom profile. Following symptom analysis, RADAR Opus software was used for repertorization, leading to the prescription of Pulsatilla in 0/1 potency, determined by repertorial totality and final consultation with materia medica. Baseline severity and progress were assessed monthly using the Hamilton Anxiety Scale (HAM-A), while the World Health Organization Quality of Life brief version (WHO QOL BREF) was administered every six months. HAM-A scores, starting at 45, decreased to 3 at the end of the one-year observation period. The Modified Naranjo Criteria for Homeopathy—Causal Attribution Inventory was utilized to establish a causal relationship between Homoeopathic intervention and outcomes.
Conclusion: These findings provide preliminary evidence supporting the potential utility of fifty millesimal potencies of individualized homeopathic medicines in managing GAD. They underscore the need for further research in this area.
Downloads
References
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, D.C.: APA; 1994.
3. World Health Organization. The ICD Classification of Mental and Behavioral Disorders. 10th ed. Delhi: A.I.T.B.S. Publishers & Distributors; 2007.
4. Pal D, Sahu DP, Maji S, Taywade M. Prevalence of Anxiety Disorder in Adolescents in India: A Systematic Review and Meta-Analysis. Cureus. 2022;14(8):e28084. https://doi.org/10.7759/cureus.28084
5. Manjunatha N, Jayasankar P, Suhas S, Rao GN, Gopalkrishna G, Varghese M, Benegal V; NMHS National Collaborators Group. Prevalence and its correlates of anxiety disorders from India's National Mental Health Survey 2016. Indian J Psychiatry. 2022;64(2):138-142. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_964_21
6. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). J Am Acad Child Adolescent Psychiatry. 2010;49(10):980–989. https://doi.org/10.1016/j.jaac.2010.05.017
7. Mishra AK, Varma AR. A Comprehensive Review of the Generalized Anxiety Disorder. Cureus. 2023;15(9):e46115. https://doi.org/10.7759/cureus.46115
8. Vesga-López O, Schneier FR, Wang S, Heimberg RG, Liu SM, Hasin DS, Blanco C. Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2008;69(10):1606–1616.
9. Munir S, Takov V. Generalized Anxiety Disorder. [Updated 2022 Oct 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441870/
10. International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021 https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO licence (CC BY-ND 3.0 IGO).
11. Therapy for Anxiety Disorders. HelpGuide.org [Internet]. HelpGuide.org. 2021. Available from: https://www.helpguide.org/articles/anxiety/therapy-for-anxietydisorders.htm.
12. Hunot V, Churchill R, Silva de Lima M, Teixeira V. Psychological therapies for generalized anxiety disorder. Cochrane Database Syst Rev. 2007;(1):CD001848. doi: 10.1002/14651858.CD001848.pub4.
13. Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry. 2020;11:595584. https://doi.org/10.3389/fpsyt.2020.595584
14. Kent JT. Lectures on Homoeopathic Philosophy. Presented by Dr Robert Séror. http://www.homeoint.org/books3/kentlect/index.htm
15. Homeobook. RadarOpus software information. Available from: https://www.radaropus.com/
16. Hahnemann S. Organon of Medicine, 5th ed. Translated by R.E. Dudgeon. B. Jain Publishers (P) Ltd; 2000.
17. Boericke W. New manual of homoeopathic materia medica and repertory: B. Jain Publishers; 2001.
18. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–.
19. World Health Organization. WHOQOL-BREF: introduction, administration, scoring, and generic version of the assessment: field trial version, December 1996. World Health Organization; 1996.
20. Lamba CD, Gupta VK, van Haselen R, Rutten L, Mahajan N, Molla AM, Singhal R. Evaluation of the Modified Naranjo Criteria for Assessing Causal Attribution of Clinical Outcome to Homeopathic Intervention as Presented in Case Reports. Homeopathy. 2020;109(4):191–197. doi: 10.1055/s-0040-1701251
21. Parewa M, Burman AS, Brahma A, Rutten L, Sadhukhan S, Misra P, Gupta B, Saklani N, Michael J, Basu A, Ali SS, Koley M, Saha S. Individualized Homeopathic Medicines in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled, Pilot Trial. Complement Med Res. 2021 Mar 4:1-11. English. Epub ahead of print. PMID: 33662951.
22. Dr. Alpesh Shah, Dr. Girish Patel, Dr. Pranav Shah. Effectiveness Of Homoeopathic Medicine In Cases Of Generalized Anxiety Disorders: Effectiveness Of Homoeopathic Medicine In Cases Of Generalized Anxiety Disorders. Natl J Integr Res Med. 2021;12(5):55-57.
23. Gilla D, Ahammed J, AL A, SR S. A Review on Anxiety Disorders During Covid-19 Pandemic: Homoeopathic Perspective. Int J High Dilution Res [Internet]. 2021 Dec 28;20(2-3):75-8.
24. Moorthi K, P R. Homoeopathy in the management of generalised anxiety disorder: A case report. Indian J Res Homoeopathy 2023;17(1). doi: 10.53945/2320-7094.1116
25. Dunlop BW, Davis PG. Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review. Prim Care Companion J Clin Psychiatry. 2008;10(3):222–228. https://doi.org/10.4088/pcc.v10n0307
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
.